Allicin Vs SARS-CoV-2

Allicin Shows Promise in Fighting SARS-CoV-2 - by dulwich Health

The Study: Allicin and SARS-CoV-2

Researchers from the Institute for Medical Microbiology, Immunology and Hygiene at the University Hospital of Cologne, Germany, have recently published a study in the journal Microorganisms examining the effects of allicin on SARS-CoV-2 infected cells. The study, conducted using Vero E6 and Calu-3 cell lines, found that allicin at biocompatible doses decreased infectious viral particles and viral RNA of SARS-CoV-2.

Key Findings:

  1. Viral Reduction: Exposure of infected Vero E6 and Calu-3 cells to biocompatible allicin doses led to a ∼60–70% decrease of viral RNA and infectious viral particles.

     

  2. Proteome Changes: Allicin reduced the abundance of the structural viral proteins N, M, S and ORF3 in the host-virus proteome.

     

  3. Immunomodulatory Effect: Allicin abrogated the interferon-stimulated gene (ISG) response and reverted several host cellular pathways to levels of uninfected cells.

What This Means for AlliTech Users

As a user of AlliTech, our stabilized allicin supplement, these findings are particularly relevant. While the study used a different allicin preparation, the results highlight the potential antiviral properties of allicin that AlliTech users may already be benefiting from.

Potential Benefits:

  • Antiviral Support: The study suggests that allicin may help inhibit SARS-CoV-2 replication, potentially offering additional protection against the virus.
  • Immune System Modulation: The research indicates that allicin may help regulate the immune response, which could be beneficial in managing the body’s reaction to viral infections.
  • Overall Health Support: These findings reinforce allicin’s role in supporting general health and immunity.

Expert Insights

Dr. Martin C. H. Gruhlke, one of the study’s authors, stated: “Our data demonstrate the antiviral and immunomodulatory activity of biocompatible doses of allicin in SARS-CoV-2-infected cell cultures.

What Should AlliTech Users Do?

  1. Consult Your Healthcare Provider: Before making any changes to your supplement routine, especially in relation to COVID-19, always consult with your healthcare provider.
  2. Maintain Your Routine: If you’re already taking AlliTech, continue your regular dosage unless advised otherwise by a medical professional.
  3. Stay Informed: Keep an eye out for further research in this area. We at Dulwich Health are committed to staying abreast of the latest scientific developments.

The Bigger Picture

This study opens up new avenues for research into natural compounds and their role in fighting viral infections. It underscores the importance of a holistic approach to health, combining modern medical advancements with natural supplements like AlliTech.

While these findings are promising, it’s important to note that they are based on in vitro studies. More research, including clinical trials, is needed to fully understand the effects of allicin on SARS-CoV-2 in humans. As always, we recommend a balanced approach to health, combining good nutrition, regular exercise, and appropriate supplementation under the guidance of healthcare professionals

 
.At Dulwich Health, we’re committed to providing you with high-quality, science-backed supplements like AlliTech. We’ll continue to monitor research developments and keep you informed about how our products can best support your health journey. Stay healthy, stay informed!
 
Interested in supporting your immune system naturally? Learn more about AlliTech and order your supply today!
 
 
 
 
 
 

References:

1Mösbauer, K., et al. (2021). The Effect of Allicin on the Proteome of SARS-CoV-2 Infected Calu-3 Cells. Microorganisms, 9(11), 2382.
2Mösbauer, K., et al. (2021). Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host response in the Calu-3 proteome. bioRxiv.